Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human YES1 Stable Cell Line

    [CAT#: S01YF-1023-PY134]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX529 Magic™ Human YES(YES1) in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;MGC-803;AGS
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cancer Research
    Related Diseases
    Sarcoma; Co-Trimoxazole Allergy
    Gene ID
    Human:7525
    UniProt ID
    Human:P07947

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    YES1, a tyrosine-protein kinase, has been implicated in various biological processes and diseases. In the context of intestinal stem cell (ISC) homeostasis, YES1 is involved in the regulation of actin polymerization, which affects ISC proliferation and differentiation. Inhibition of actin polymerization by targeting the ARPC2 protein leads to changes in ISC behavior and intestinal epithelial cell migration. In lung adenocarcinoma, YES1 is associated with the ASCL1-positive subtype, where it regulates the expression of microRNAs and the suppression of ZFP36L1, a target gene of miR-124-3p. In small-cell lung carcinoma, YES1 is one of the proteins used to classify molecular subtypes, along with ASCL1, NEUROD1, POU2F3, and YAP1. In osteoporosis, extracellular vesicles derived from bone marrow mesenchymal stem cells deliver YES1 and stabilize YAP1 protein, leading to activation of the Wnt/β-catenin pathway and promotion of bone formation. Finally, in the context of epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp, YES1 is upregulated in T cells and may play a role in mediating the cutaneous adverse reaction. Overall, YES1 has diverse applications in various biological processes and diseases, including stem cell homeostasis, cancer, bone regeneration, and drug-induced skin reactions.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human YES1 Stable Cell Line (S01YF-1023-PY134). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Jordan Garcia (Verified Customer)

    What is the significance of YES1 in cancer therapy? Aug 20 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Inhibiting YES1 in tumors with high expression of this protein is a promising strategy against various cancers. Aug 20 2020

    chat Jordan Miller (Verified Customer)

    How does YES1 contribute to gastric cancer progression? Feb 14 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    YES1 is involved in gastric cancer progression by enhancing YAP1 nuclear translocation, which is crucial for tumor growth and differentiation. Feb 14 2022

    Published Data

    Fig.1 YES1 promotes GC cell proliferation.

    In the upper panel, we conducted CCK8 analysis to assess the proliferation of MGC-803 cells overexpressing YES1 and AGS cells with YES1 knockdown, comparing them to their respective control groups. In the lower panel, we present representative images and quantitative data from a soft agar colony formation assay, which illustrates the impact of YES1 overexpression in MGC-803 cells and YES1 knockdown in AGS cells, alongside their respective control counterparts.

    Ref: Mao, Linfeng, et al. "EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis." Oncogene 40.20 (2021): 3610-3623.

    Pubmed: 33941853

    DOI: 10.1038/s41388-021-01786-6

    Research Highlights

    Zhang, Ruzhen. et al. "Actin polymerization inhibition by targeting ARPC2 affects intestinal stem cell homeostasis." Burns & trauma, 2023.
    In this research, the focus is on the turnover of intestinal epithelial cells driven by intestinal stem cells and the role of F-actin cytoskeleton dynamics in this process. They investigate the impact of benproperine (BPP), an anti-tumor drug, on this homeostasis. The study utilizes various methods, including fluorescence staining, flow cytometry, and organoid culture, to assess cell proliferation, differentiation, and migration. Results show that F-actin content increases during cell migration, particularly in Paneth cells, and BPP treatment affects organoid growth, cell proliferation, and gene expression related to intestinal stem cells and Paneth cell differentiation. This suggests a potential novel approach using BPP to influence intestinal epithelial cell turnover through cytoskeleton regulation.
    Zhang, Ruzhen. et al. "Actin polymerization inhibition by targeting ARPC2 affects intestinal stem cell homeostasis." Burns & trauma, 2023.
    Pubmed: 37849945   DOI: 10.1093/burnst/tkad038

    Enokido, Takayoshi. et al. "Distinct microRNA signature and suppression of ZFP36L1 define ASCL1-positive lung adenocarcinoma." Molecular cancer research : MCR, 2023.
    Achaete-scute family bHLH transcription factor 1 (ASCL1) serves as a key transcription factor in neuroendocrine differentiation and is found in roughly 10% of lung adenocarcinomas, contributing to tumor progression. The study delved into the microRNA (miRNA) patterns in ASCL1-positive lung adenocarcinomas and pinpointed several closely linked miRNAs, including miR-375, miR-95-3p/miR-95-5p, miR-124-3p, and members of the miR-17~92 family. These findings mirror the suppression of Yes1 associated transcriptional regulator (YAP1), a notable target of miR-375, observed in ASCL1-positive lung adenocarcinomas. The research also highlighted ASCL1's positive influence on miR-124-3p and miR-17~92 family members, underscoring ZFP36 ring finger protein like 1 (ZFP36L1) as a miR-124-3p target gene, while demonstrating low ZFP36L1 protein levels in ASCL1-positive lung adenocarcinomas. This study disclosed that the downregulation of ZFP36L1 by ASCL1-controlled miR-124-3p can impact gene expression, elucidating the role of ASCL1 in shaping the molecular characteristics of ASCL1-positive lung adenocarcinomas and suggesting potential clinical implications.
    Enokido, Takayoshi. et al. "Distinct microRNA signature and suppression of ZFP36L1 define ASCL1-positive lung adenocarcinoma." Molecular cancer research : MCR, 2023.
    Pubmed: 37801008   DOI: 10.1158/1541-7786.MCR-23-0229

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare